Trends in amphetamine and benzodiazepine use among drivers arrested for drug impaired driving in Norway 2000-2009

Norsk Epidemiologi

Volumn 21, Issue 1, 2011, Pages 61-66

  Bogstrand, Stig Tore ^a,b   Middelkoop, Gerrit ^a   Christophersen, Asbjorg S ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE; CLONAZEPAM; DIAZEPAM; FLUNITRAZEPAM; METHAMPHETAMINE;

ARTICLE; BLOOD ANALYSIS; CAR DRIVER; CAR DRIVING; CLINICAL EXAMINATION; CONTROLLED STUDY; DOPING; HIGH RISK BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; NORWAY; RISK REDUCTION; SEIZURE; SUBSTANCE ABUSE; TRAFFIC ACCIDENT; TREND STUDY;

EID: 84855804031     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i1.1427     Document Type: Article

References (25)

1. Christophersen AS, Skurtveit S, Grung M, Mørland J. Rearrest rates among Norwegian drugged drivers compared with drunken drivers. Drug Alcohol Depend 2002; 66: 85-92.
2. Christophersen AS, Skurtveit S, Mørland J. [Impaired driving as an indicator of drug abuse: what consequences for treatment?]. Tidsskr Nor Laegeforen 2003; 123: 1841-3.
3. Christophersen AS, Mørland J. Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev 2008; 9: 98-104.
4. Christophersen AS, Morland J. Drugged driving, a review based on the experience in Norway. Drug Alcohol Depend 1997; 47: 125-35.
5. Khiabani HZ, Christophersen AS, Morland J. Routines upon suspicion of driving under influence. Tidsskr Nor Laegeforen 2007; 127: 618-9.
6. Hausken AM, Skurtveit S, Christophersen AS. Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs. Drug Alcohol Depend 2005; 79: 423-9.
7. KRIPOS. Narkotika og dopingstatistikk 2010. 2010.
8. Baselt RC. Disposition of toxic drugs and chemicals in man, 8th edn. Foster City, CA: Biomedical Publications, 2008.
9. Christophersen AS, Gulliksen M, Hasvold I, Johansen U, Karinen R, Ripel A, et al. Screening, confirmation and quantification of drugs of abuse in whole blood by LC- MS (ESI). In: Abstracts of The 39th Meeting of The International Association of Forensic Toxicologists (TIAFT). Prague, 2001.
10. Øiestad EL, Johansen U, Øiestad AM, Christophersen AS. Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 2011; 35: 280-93.
11. Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Mørland J. Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci Int 1990; 44: 179-85.
12. Gjerde H, Hasvold I, Pettersen G, Christophersen AS. Determination of amphetamine and methamphetamine in blood by derivatization with perfluorooctanoyl chloride and gas chromatography/mass spectrometry. J Anal Toxicol 1993; 17: 65-8.
13. Griffiths P, Mravcik V, Lopez D, Klempova D. Quite a lot of smoke but very limited fire - the use of meth-amphetamine in Europe. Drug Alcohol Rev 2008; 27: 236-42.
14. EMCDDA. Problem amphetamine and methamphetamine use in Europe. Luxembourg: Publications Office of the European Union, 2010.
15. Holmgren A, Holmgren P, Kugelberg FC, Jones AW, Ahlner J. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden. Traffic Inj Prev 2007; 8: 361-7.
16. Ojaniemi KK, Lintonen TP, Impinen AO, Lillsunde PM, Ostamo AI. Trends in driving under the influence of drugs: a register-based study of DUID suspects during 1977-2007. Accid Anal Prev 2009; 41: 191-6.
17. EMCDDA. 2010 Annual report on the state of the drugs problem in Europe. Lisbon: EMCDDA, 2010.
18. Bogstrand ST, Normann PT, Rossow I, Larsen M, Mørland J, Ekeberg Ø. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department. Drug Alcohol Depend 2011; 117: 132-8.
19. Hordvin O. The Drug Situation in Norway 2010. Oslo: SIRUS, 2010.
20. Fitzpatrick P, Daly L, Leavy CP, Cusack DA. Drinking, drugs and driving in Ireland: more evidence for action. Inj Prev 2006; 12: 404-8.
21. Toth AR, Varga T, Molnar A, Hideg Z, Somogyi G. The role of licit and illicit drugs in traffic (Hungary 2000-2007). Leg Med (Tokyo) 2009; 11 Suppl 1: S419-22.
22. Senna MC, Augsburger M, Aebi B, Briellmann TA, Donze N, Dubugnon JL, et al. First nationwide study on driving under the influence of drugs in Switzerland. Forensic Sci Int 2010; 198: 11-6.
23. Steentoft A, Simonsen KW, Linnet K. The frequency of drugs among Danish drivers before and after the introduction of fixed concentration limits. Traffic Inj Prev 2010; 11: 329-33.
24. Ekeberg Ø, Jacobsen D, Flaaten B, Mack A. Effect of regulatory withdrawal of drugs and prescription recommendations on the pattern of self-poisonings in Oslo. Acta Med Scand 1987; 221: 483-7.
25. Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M. [Changes in the sale and use of flunitrazepam in Norway after 1999]. Tidsskr Nor Laegeforen 2006; 126: 589-90.